Very good Phase 1 results reported for TSRX's next leading antibiotic compound out of Japan... Report came after the close today. Should see the stock up tomorrow. In from 5.17. Posted purely for anyone who may own it on this Board.
Congrats to Siga longs on the recent run up in the share price. Nice job.
Thanks again for bring "Trius" to the board's attention. I like the fact that Trius's drug has a lower impact on "platelets" than Pfizer's drug. The "doctors" will appreciate that fact also. If things go right, and it appears we will get approval, we could really have a tiger by the tail.